Rifamycin Drugs as Alternatives to Standard Isoniazid Treatment to Prevent Active Tuberculosis (TB) in HIV-negative People at Risk of Developing Active TB

Clinical Epidemiology and Global Health - Netherlands
doi 10.1016/j.cegh.2013.12.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Childhood TB Epidemiology and Treatment Outcomes in Thailand: A TB Active Surveillance Network, 2004 to 2006

BMC Infectious Diseases
Infectious Diseases
2008English

Infant TB Infection Prevention Study (iTIPS): A Randomised Trial Protocol Evaluating Isoniazid to Prevent M. Tuberculosis Infection in HIV-exposed Uninfected Children

BMJ Open
Medicine
2020English

Toxicity Related to Standard TB Therapy for Pulmonary Tuberculosis and Treatment Outcomes in the REMoxTB Study According to HIV Status

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2019English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Characteristics of Patients With Smear-Negative Pulmonary Tuberculosis (TB) in a Region With High TB and HIV Prevalence

PLoS ONE
Multidisciplinary
2016English

Coagulopathy on TB Treatment Naive HIV Negative Patients Initiating Anti TB Medications at Thika Level Five Hospital in Kenya

Journal of Medical Science And clinical Research
2019English

Prognostic Score to Predict Mortality During TB Treatment in TB/HIV Co-Infected Patients

PLoS ONE
Multidisciplinary
2018English

Profile of Tuberculosis and Its Response to Anti-Tb Drugs Among Tuberculosis Patients Treated Under the TB Control Programme at Felege-Hiwot Referral Hospital, Ethiopia

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2016English

QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis Patients and Healthy Adults

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy